Somatostatin receptor subtypes: Basic pharmacology and tissue distribution

Digestive and Liver Disease

Volumn 36, Issue SUPPL. 1, 2004, Pages

  Corleto, V D ^a   Nasoni, S ^a   Panzuto, F ^a   Cassetta, S ^a   Delle Fave, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Seven transmembrane receptors; Somatostatin receptor pharmacology; Somatostatin receptor subtype expression

Indexed keywords

ADENYLATE CYCLASE; G PROTEIN COUPLED RECEPTOR; MEMBRANE RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PASIREOTIDE; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

AMINO ACID SEQUENCE; BRAIN TISSUE; CELL MEMBRANE; COLORECTAL CANCER; DEGRADATION KINETICS; ENZYME ACTIVITY; GENETIC CONSERVATION; GROWTH INHIBITION; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNALIZATION; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; TREATMENT FAILURE; ANIMAL; METABOLISM;

ANIMALS; HUMANS; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 2442701779     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2003.11.008     Document Type: Article

References (64)

1. Brazeau P, Vale WW, Burgus R, Ling N, Butcher M, Rivier J, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.
2. Burgus R, Ling N, Butcher M, Guillemin R. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci USA 1973;70:684-8.
3. Pradayrol L, Jornvall H, Mutt V, Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett 1980;1:55-8.
4. Corleto VD, Delle Fave G. Role of somatostatin in the human gastrointestinal tract. Curr Opin Endocrinol Diab 2003;10:72-7.
5. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999;20:157-98.
6. Walsh JS. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven Press; 1994. p. 31-48.
7. Schonbrunn A, Tashjian Jr H. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J Biol Chem 1978;253:6473-83.
8. Reichlin S. Somatostatin. N Engl J Med 1983;309:1495-501.
9. Patel YC, Murthy KK, Escher EE, Banville D, Spiess J, Srikant CB. Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 1990;39(Suppl 2):63-9.
10. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995;16:427-42.
11. Reubi JC, Horisberger U, Kappeler A, Laissue JA. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood 1998;92:191-7.
12. Mandarine L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, et al. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature 1981;291:76-7.
13. Srikant CB, Patel YC. Receptor binding of somatostatin-28 is tissue specific. Nature 1981;294:259-60.
14. Murthy KS, Coy DH, Makhlouf GM. Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao. J Biol Chem 1996;271:23458-63.
15. Hervieu G, Emson PC. The localization of somatostatin receptor 1 (sstl) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience 1998;85:1263-84.
16. Patel YC, Greenwood M, Kent G, Panetta R, Srikant CB. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun 1993;192:288-94.
17. Lewin MJ. The somatostatin receptor in the GI tract. Annu Rev Physiol 1992;54:455-68.
18. Patel YC. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997;20:348-67.
19. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995;16:427-42.
20. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB. The somatostatin receptor family. Life Sci 1995;57:1249-65.
21. Corleto VD, Weber HC, Jensen RT. Expression of somatostatin receptor subtypes on guinea pig gastric and colonic smooth muscle cells. Am J Physiol 1999;277:G235-44.
22. Chadwick DJ, Garden G. Somatostatin and its receptors. West Sussex, UK: Wiley; 1995. p. 1-274.
23. Reisine T, Bell GI. Molecular properties of somatostatin receptors. Neuroscience 1995;67:777-90.
24. D'Erchia AM, Gissi C, Pesole G, Saccone C, Arnason U. The guinea-pig is not a rodent. Nature 1996;38:597-600.
25. Archer E, Maigret B, Escrieut C, Pradayrol L, Fourmy D. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol Sci 2003;24:36-40.
26. Drews J. Drug discovery: a historical perspective. Science 2000;287:1960-4.
27. Baldwin JM. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol 1994;6:180-90.
28. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA. Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994;63:101-32.
29. Schwartz TW, Rosenkilde MM. Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sci 1996;17:213-6.
30. Kaupmann K, Bruns C, Raulf F, Weber HP, Mattes H, Lubbert H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J 1995;14:727-35.
31. Nehring RB, Meyerhof W, Richter D. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol 1995;14:939-44.
32. Strnad J, Hadcock JR. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem Biophys Res Commun 1995;216:913-21.
33. Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 2002;146:707-16.
34. Lamberts SW, van der Lely AJ, Hofland LJ. New somatostatin analogs: will they fulfil old promises? Eur J Endocrinol 2002;146:701-5.
35. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991;60:653-88.
36. Zhang J, Barak LS, Winkler KE, Caron MG, Ferguson SS. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem 1997;272:27005-14.
37. Thomas RF, Holt BD, Schwinn DA, Liggett SB. Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA 1992;89:4490-4.
38. Akiyoshi J, Hough C, Chuang DM. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation. Mol Pharmacol 1993;43:349-55.
39. Zhang LJ, Lachowicz JE, Sibley DR. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 1994;45:878-89.
40. Hukovic N, Panetta R, Kumar U, Patel YC. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 1996;137:4046-9.
41. Hukovic N, Rocheville M, Kumar U, Sasi R, Khare S, Patel YC. Agonist-dependent up-regulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail. J Biol Chem 1999;274:24550-8.
42. Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WA, Lamberts SW. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology 1995;136:3698-706.
43. Koenig JA, Edwardson JM, Humphrey PP. Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br J Pharmacol 1997;120:52-9.
44. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991;254:821-5.
45. Greenlund AC, Schreiber RD, Goeddel DV, Pennica D. Interferon-gamma induces receptor dimerization in solution and on cells. J Biol Chem 1993;268:18103-10.
46. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
47. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, et al. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA 2002;99:3294-9.
48. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54.
49. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 2000;288:154-7.
50. Casini Raggi C, Calabro A, Renzi D, Briganti V, Cianchi F, Messerini L, et al. Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. Clin Cancer Res 2002;8:419-27.
51. Vuaroqueaux V, Dutour A, Briard N, Monges G, Grino M, Oliver C, et al. No loss of sst receptors gene expression in advanced stages of colorectal cancer. Eur J Endocrinol 1999;140:362-6.
52. Laws SA, Gough AC, Evans AA, Bains MA, Primrose JN. Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae. Br J Cancer 1997;75:360-6.
53. Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002;440:461-75.
54. Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y, et al. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 2002;50:52-60.
55. Oda Y, Tanaka Y, Naruse T, Sasanabe R, Tsubamoto M, Funahashi H. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors. Surg Today 2002;32: 690-4.
56. Kimura N, Pilichowska M, Date F, Kimura I, Schindler M. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 1999;5:3483-7.
57. Jais P, Terris B, Ruszniewski P, LeRomancer M, Reyl-Desmars F, Vissuzaine C, et al. Somatostatin receptor subtype gene expression in human endocrine gastro-pancreatic tumours. Eur J Clin Invest 1997;27:639-44.
58. John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scherubl H, et al. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 1996;38:33-9.
59. Janson ET, Gobi A, Kalkner KM, Oberg K. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. Cancer Res 1996;56:2561-5.
60. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 1995;80: 2974-9.
61. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994;93: 1321-5.
62. Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994;54:3455-9.
63. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1999;48:77-85.
64. Corleto VD, Ciardi S, Angeletti S, Lahner E, Moretti A, Cannoni C, et al. Relationship between Somatostatin receptor subtypes (sst) and clinical outcome on patients with digestive neuroendocrine tumors. Gastroenterology 2000;118(Suppl 2): A642.